These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6863324

  • 21. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series.
    Pichichero ME, Barkin RM, Samuelson JS.
    Pediatr Infect Dis; 1986; 5(4):428-30. PubMed ID: 3487779
    [Abstract] [Full Text] [Related]

  • 22. Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease.
    Kung FH, Orgel HA, Wallace WW, Hamburger RN.
    Pediatrics; 1984 Jul; 74(1):86-9. PubMed ID: 6588361
    [Abstract] [Full Text] [Related]

  • 23. Immunogenicity testing of diphtheria and tetanus vaccines by using isogenic mice with possible implications for potency testing.
    Hendriksen CF, Slob W, vd Gun JW, Westendorp JH, den Bieman M, Hesp A, van Zutphen LF.
    Lab Anim; 1994 Apr; 28(2):121-9. PubMed ID: 8035562
    [Abstract] [Full Text] [Related]

  • 24. Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults.
    Halperin SA, Smith B, Russell M, Scheifele D, Mills E, Hasselback P, Pim C, Meekison W, Parker R, Lavigne P, Barreto L.
    Pediatr Infect Dis J; 2000 Apr; 19(4):276-83. PubMed ID: 10783014
    [Abstract] [Full Text] [Related]

  • 25. Comparison of immune responses to diphtheria and tetanus toxoids of various mouse strains.
    Kameyama S, Nagaoka F, Matuhasi T.
    Jpn J Med Sci Biol; 1989 Jun; 42(3):83-99. PubMed ID: 2630688
    [Abstract] [Full Text] [Related]

  • 26. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults.
    Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, Meekison W, Parker R, Lavigne P, Barreto L.
    Vaccine; 2000 Jan 31; 18(14):1312-9. PubMed ID: 10618527
    [Abstract] [Full Text] [Related]

  • 27. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
    Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR.
    Pediatrics; 2006 Apr 31; 117(4):1084-93. PubMed ID: 16585302
    [Abstract] [Full Text] [Related]

  • 28. Significance of the Lf content of diphtheria toxoid as a guide to its immunogenic value in DPT vaccine.
    Habbu MK, Poonawalla CS, Parvatikar MS, Jadhav SS.
    Indian Pediatr; 1987 Feb 31; 24(2):141-4. PubMed ID: 3499394
    [No Abstract] [Full Text] [Related]

  • 29. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines.
    Csizér Z, Zsidai J.
    Ann Immunol Hung; 1979 Feb 31; 19():53-74. PubMed ID: 552225
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H.
    Verh K Acad Geneeskd Belg; 2000 Feb 31; 62(4):245-67. PubMed ID: 11004905
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Processing of preparations for the determination of immunogenic activity of adsorbed diphtheria and tetanus toxoids].
    Sporzyńska Z, Albrycht H.
    Med Dosw Mikrobiol; 1970 Feb 31; 22(3):231-42. PubMed ID: 5483149
    [No Abstract] [Full Text] [Related]

  • 36. Effect of different concentrations of diphtheria toxoid & aluminum phosphate on potency of diphtheria component in DPT vaccines.
    Gupta P, Saxena SN, Kumar A, Gupta P.
    Indian J Med Res; 1990 May 31; 91():171-3. PubMed ID: 2118880
    [Abstract] [Full Text] [Related]

  • 37. An evaluation of some proposals for a reduction in the number of animals used for the potency testing of diphtheria and tetanus vaccines.
    Knight PA, Roberts PA.
    J Biol Stand; 1987 Apr 31; 15(2):165-75. PubMed ID: 3597449
    [Abstract] [Full Text] [Related]

  • 38. Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants.
    Pichichero ME, Francis AB, Marsocci SM, Green JL, Disney FA.
    Am J Dis Child; 1993 Mar 31; 147(3):295-9. PubMed ID: 8438811
    [Abstract] [Full Text] [Related]

  • 39. Studies on adjuvants for human prophylactics. I. Comparison of efficiencies of different adjuvants at various stages of immunization with tetanus and diphtheria toxoids.
    Yamamoto A, Kondo S, Kameyama S, Murata R.
    Jpn J Med Sci Biol; 1978 Jun 31; 31(3):263-76. PubMed ID: 732031
    [Abstract] [Full Text] [Related]

  • 40. Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids.
    Sutjita M, Hohmann A, Comacchio R, Bradley J.
    Clin Exp Immunol; 1988 Aug 31; 73(2):191-7. PubMed ID: 3263226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.